IBD Drugs 'Prohibitively' Expensive for Medicare Patients

Over their lifetime, Medicare patients with IBD can expect to shell out tens to hundreds of thousands of dollars in out-of-pocket costs for needed medications.
Medscape Medical News

source https://www.medscape.com/viewarticle/982908?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost